Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Oncotarget|September 17, 2017
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockadeThomas W Flaig, Maren Salzmann-Sullivan, Lih-Jen Su, et al.
The Prostate|February 21, 2018
The effect of digital rectal exam on the 4Kscore for aggressive prostate cancerMichael A Maccini, Nicholas J Westfall, Adrie Van Bokhoven, et al.
Urology|May 15, 2014
Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention TrialWilliam D Figg, Cindy H Chau, Douglas K Price, et al.
Cancer Medicine|January 10, 2019
Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patientsGati K Panigrahi, Prakash P Praharaj, Hiroki Kittaka, et al.
Nature Reviews. Urology|December 19, 2018
Urologic chronic pelvic pain syndrome: insights from the MAPP Research NetworkJ Quentin Clemens, Chris Mullins, A Lenore Ackerman, et al.
BJU International|March 7, 2017
Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research NetworkAdelle Dagher, Adam Curatolo, Monisha Sachdev, et al.
The Journal of Urology|October 7, 2020
Association of Longitudinal Changes in Symptoms and Urinary Biomarkers in Patients with Urological Chronic Pelvic Pain Syndrome: A MAPP Research Network StudyRoopali Roy, Alisa J Stephens, Cassandra Daisy, et al.
Cancer Research Communications|March 11, 2026
Metastasis-associated wound repair promotes reciprocal lung epithelium activation and breast cancer metastatic outgrowthJessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Cancer Research Communications|April 6, 2026
Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic OutgrowthJessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
Pageof 6